These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 27634302)
21. Polycomb Repressive Complex 2 in Oncology. Guo Y; Yu Y; Wang GG Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005 [TBL] [Abstract][Full Text] [Related]
22. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer. Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289 [TBL] [Abstract][Full Text] [Related]
23. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis. Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897 [TBL] [Abstract][Full Text] [Related]
25. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response. Turgeon N; Blais M; Delabre JF; Asselin C J Cell Biochem; 2013 May; 114(5):1203-15. PubMed ID: 23192652 [TBL] [Abstract][Full Text] [Related]
26. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs. Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884 [TBL] [Abstract][Full Text] [Related]
27. Activation of automethylated PRC2 by dimerization on chromatin. Sauer PV; Pavlenko E; Cookis T; Zirden LC; Renn J; Singhal A; Hunold P; Hoehne-Wiechmann MN; van Ray O; Kaschani F; Kaiser M; Hänsel-Hertsch R; Sanbonmatsu KY; Nogales E; Poepsel S Mol Cell; 2024 Oct; 84(20):3885-3898.e8. PubMed ID: 39303719 [TBL] [Abstract][Full Text] [Related]
28. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation. Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722 [TBL] [Abstract][Full Text] [Related]
29. Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development. Dauber KL; Perdigoto CN; Valdes VJ; Santoriello FJ; Cohen I; Ezhkova E J Invest Dermatol; 2016 Aug; 136(8):1647-1655. PubMed ID: 26994968 [TBL] [Abstract][Full Text] [Related]
30. The polycomb repressive complex 2 is a potential target of SUMO modifications. Riising EM; Boggio R; Chiocca S; Helin K; Pasini D PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979 [TBL] [Abstract][Full Text] [Related]
31. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737 [TBL] [Abstract][Full Text] [Related]
32. Cryptic RNA-binding by PRC2 components EZH2 and SUZ12. Betancur JG; Tomari Y RNA Biol; 2015; 12(9):959-65. PubMed ID: 26177152 [TBL] [Abstract][Full Text] [Related]
33. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Chamberlain SJ; Yee D; Magnuson T Stem Cells; 2008 Jun; 26(6):1496-505. PubMed ID: 18403752 [TBL] [Abstract][Full Text] [Related]
34. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2. Kong X; Chen L; Jiao L; Jiang X; Lian F; Lu J; Zhu K; Du D; Liu J; Ding H; Zhang N; Shen J; Zheng M; Chen K; Liu X; Jiang H; Luo C J Med Chem; 2014 Nov; 57(22):9512-21. PubMed ID: 25369470 [TBL] [Abstract][Full Text] [Related]
35. Mutations and deletions of PRC2 in prostate cancer. Jain P; Di Croce L Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413 [TBL] [Abstract][Full Text] [Related]
36. Structural basis for PRC2 engagement with chromatin. Glancy E; Ciferri C; Bracken AP Curr Opin Struct Biol; 2021 Apr; 67():135-144. PubMed ID: 33232890 [TBL] [Abstract][Full Text] [Related]
37. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells. Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214 [TBL] [Abstract][Full Text] [Related]
38. Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits. Youmans DT; Schmidt JC; Cech TR Genes Dev; 2018 Jun; 32(11-12):794-805. PubMed ID: 29891558 [TBL] [Abstract][Full Text] [Related]
39. A model for transmission of the H3K27me3 epigenetic mark. Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660 [TBL] [Abstract][Full Text] [Related]
40. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis. Marchesi I; Giordano A; Bagella L Cell Cycle; 2014; 13(4):516-27. PubMed ID: 24496329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]